363 related articles for article (PubMed ID: 12795331)
1. COPD exacerbations: definitions and classifications.
Burge S; Wedzicha JA
Eur Respir J Suppl; 2003 Jun; 41():46s-53s. PubMed ID: 12795331
[TBL] [Abstract][Full Text] [Related]
2. Infections and airway inflammation in chronic obstructive pulmonary disease severe exacerbations.
Papi A; Bellettato CM; Braccioni F; Romagnoli M; Casolari P; Caramori G; Fabbri LM; Johnston SL
Am J Respir Crit Care Med; 2006 May; 173(10):1114-21. PubMed ID: 16484677
[TBL] [Abstract][Full Text] [Related]
3. What is a COPD exacerbation? Current definitions, pitfalls, challenges and opportunities for improvement.
Kim V; Aaron SD
Eur Respir J; 2018 Nov; 52(5):. PubMed ID: 30237306
[TBL] [Abstract][Full Text] [Related]
4. Patient-reported Outcomes for the Detection, Quantification, and Evaluation of Chronic Obstructive Pulmonary Disease Exacerbations.
Mackay AJ; Kostikas K; Murray L; Martinez FJ; Miravitlles M; Donaldson G; Banerji D; Patalano F; Wedzicha JA
Am J Respir Crit Care Med; 2018 Sep; 198(6):730-738. PubMed ID: 29671615
[TBL] [Abstract][Full Text] [Related]
5. Detection and severity grading of COPD exacerbations using the exacerbations of chronic pulmonary disease tool (EXACT).
Mackay AJ; Donaldson GC; Patel AR; Singh R; Kowlessar B; Wedzicha JA
Eur Respir J; 2014 Mar; 43(3):735-44. PubMed ID: 23988767
[TBL] [Abstract][Full Text] [Related]
6. 'Exacerbation-free time' to assess the impact of exacerbations in patients with chronic obstructive pulmonary disease (COPD): a prospective observational study.
Boer LM; Bischoff EW; Borgijink X; Vercoulen JH; Akkermans RP; Kerstjens HAM; Assendelft WJ; Schermer TR
NPJ Prim Care Respir Med; 2018 Apr; 28(1):12. PubMed ID: 29615628
[TBL] [Abstract][Full Text] [Related]
7. Exacerbations of chronic obstructive pulmonary disease.
Wedzicha JA; Donaldson GC
Respir Care; 2003 Dec; 48(12):1204-13; discussion 1213-5. PubMed ID: 14651761
[TBL] [Abstract][Full Text] [Related]
8. Colds as predictors of the onset and severity of COPD exacerbations.
Johnston NW; Olsson M; Edsbäcker S; Gerhardsson de Verdier M; Gustafson P; McCrae C; Coyle PV; McIvor RA
Int J Chron Obstruct Pulmon Dis; 2017; 12():839-848. PubMed ID: 28331305
[TBL] [Abstract][Full Text] [Related]
9. Airway inflammation in COPD: physiological outcome measures and induced sputum.
Crapo RO; Jensen RL; Hargreave FE
Eur Respir J Suppl; 2003 Jun; 41():19s-28s. PubMed ID: 12795328
[TBL] [Abstract][Full Text] [Related]
10. COPD exacerbations associated with the modified Medical Research Council scale and COPD assessment test among Humana Medicare members.
Pasquale MK; Xu Y; Baker CL; Zou KH; Teeter JG; Renda AM; Davis CC; Lee TC; Bobula J
Int J Chron Obstruct Pulmon Dis; 2016; 11():111-21. PubMed ID: 26834468
[TBL] [Abstract][Full Text] [Related]
11. Impact of mild exacerbation on COPD symptoms in a Japanese cohort.
Sato M; Chubachi S; Sasaki M; Haraguchi M; Kameyama N; Tsutsumi A; Takahashi S; Nakamura H; Asano K; Betsuyaku T
Int J Chron Obstruct Pulmon Dis; 2016; 11():1269-78. PubMed ID: 27354785
[TBL] [Abstract][Full Text] [Related]
12. How should we define and classify exacerbations in chronic obstructive pulmonary disease?
Trigueros Carrero JA
Expert Rev Respir Med; 2013 Apr; 7(2 Suppl):33-41. PubMed ID: 23551022
[TBL] [Abstract][Full Text] [Related]
13. Relationship between bacterial colonisation and the frequency, character, and severity of COPD exacerbations.
Patel IS; Seemungal TA; Wilks M; Lloyd-Owen SJ; Donaldson GC; Wedzicha JA
Thorax; 2002 Sep; 57(9):759-64. PubMed ID: 12200518
[TBL] [Abstract][Full Text] [Related]
14. Relationship between the presence of bronchiectasis and acute exacerbation in Thai COPD patients.
Kawamatawong T; Onnipa J; Suwatanapongched T
Int J Chron Obstruct Pulmon Dis; 2018; 13():761-769. PubMed ID: 29535516
[TBL] [Abstract][Full Text] [Related]
15. Underreporting exacerbation of chronic obstructive pulmonary disease in a longitudinal cohort.
Langsetmo L; Platt RW; Ernst P; Bourbeau J
Am J Respir Crit Care Med; 2008 Feb; 177(4):396-401. PubMed ID: 18048806
[TBL] [Abstract][Full Text] [Related]
16. Validation of a New Risk Measure for Chronic Obstructive Pulmonary Disease Exacerbation Using Health Insurance Claims Data.
Stanford RH; Nag A; Mapel DW; Lee TA; Rosiello R; Vekeman F; Gauthier-Loiselle M; Duh MS; Merrigan JF; Schatz M
Ann Am Thorac Soc; 2016 Jul; 13(7):1067-75. PubMed ID: 27070274
[TBL] [Abstract][Full Text] [Related]
17. Relation of sputum inflammatory markers to symptoms and lung function changes in COPD exacerbations.
Bhowmik A; Seemungal TA; Sapsford RJ; Wedzicha JA
Thorax; 2000 Feb; 55(2):114-20. PubMed ID: 10639527
[TBL] [Abstract][Full Text] [Related]
18. The Association of Depressive Symptoms With Rates of Acute Exacerbations in Patients With COPD: Results From a 3-year Longitudinal Follow-up of the ECLIPSE Cohort.
Yohannes AM; Mülerová H; Lavoie K; Vestbo J; Rennard SI; Wouters E; Hanania NA
J Am Med Dir Assoc; 2017 Nov; 18(11):955-959.e6. PubMed ID: 28733182
[TBL] [Abstract][Full Text] [Related]
19. Characterizing and quantifying the symptomatic features of COPD exacerbations.
Jones PW; Chen WH; Wilcox TK; Sethi S; Leidy NK;
Chest; 2011 Jun; 139(6):1388-1394. PubMed ID: 21071529
[TBL] [Abstract][Full Text] [Related]
20. Development and initial validation of the bronchiectasis exacerbation and symptom tool (BEST).
Artaraz A; Crichton ML; Finch S; Abo-Leyah H; Goeminne P; Aliberti S; Fardon T; Chalmers JD
Respir Res; 2020 Jan; 21(1):18. PubMed ID: 31931782
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
